Drug
Fluzoparib
Fluzoparib: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fluzoparib NCT04300114 | Phase 3 | Metastatic Pancreatic Cancer |
| Fluzoparib NCT03062982 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Fluzoparib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.